Glenmark launches hypertension awareness symbol jointly with API and HSI

July 18, 2020 0 By FM

Glenmark Pharmaceuticals, in collaboration with Association of Physicians of India (API) and Hypertension Society of India (HSI), has launched a new hypertension awareness symbol, in light of the growing burden of the disease emphasising the need for timely screening in the society. The symbol is developed in consultation with 50,000 leading doctors in the country, announced the drug company.

Glenmark has also pledged on-ground support to the cause, by committing to screen 5 million people for hypertension, through screening kiosks at corporate hospitals in all major metro cities. Further, a task force of 200 people has been set up to conduct screening camps throughout the year in non-metros and remote parts of the country.

Hypertension is one of the biggest risk factors for heart disease, stroke and kidney disease. The condition is directly responsible for 29% of all strokes and 24% of heart attacks in India. These advanced diseases pose a major burden on the country’s healthcare infrastructure and contribute to high rates of morbidity and mortality.

“Hypertension is the most preventable cause of heart disease and stroke, yet it is rarely diagnosed in time because of its silent symptoms. It hits Indians at a far younger age than western populations, with many heart attacks and strokes occurring a decade earlier on average. The only way to catch it is through regular and timely community screenings.” commented, Dr Shashank Joshi, Consulting Endocrinologist – Mumbai, Dean of Indian College of Physicians.

Early and timely diagnosis is key to preventing the disease from advancing to more serious secondary complications.

Dr Hemant Thacker, Consultant in Cardio-Metabolic disorders – Breach Candy & Bhatia Hospital Mumbai, said, “Without doubt, hypertension is one of those conditions where awareness plays a major role in disease management. This combined with regular screening will drive early detection and early initiation of treatment, which in turn will lead to fewer lives lost to hypertension.”